Endothelin 1 is associated with heart failure hospitalization and long-term mortality in patients with heart failure with preserved ejection fraction and pulmonary hypertension
Cardiology Sep 20, 2019
Chowdhury MA, Moukarbel GV, Gupta R, et al. - In this single center prospective cohort study, researchers focused on the role of big endothelin 1, endothelin 1 (ET1), and neprilysin in heart failure with preserved ejection fraction (HFpEF) with pulmonary hypertension (PH). Participants were 90 patients having HFpEF; 30 with no PH, 30 with postcapillary PH, and 30 with combined post- and precapillary PH. Increased ET1 in pulmonary veins (endothelin from the wedge; ET1W) was seen in patients with HFpEF-PH vs controls. The link of ET1W levels with both PH and pulmonary vascular resistance was identified. In HFpEF patients, 1-year heart failure hospitalization was predicted by ET1W and ET1 gradient (ET1G), while a link was evident between elevated ET1G levels and long-term mortality. ET1 was shown to have a role in PH development in HFpEF. The potential of ET1 as a prognostic biomarker was also explored.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries